Lecithin in the treatment of Gilles de la Tourette's syndrome
Abstract
Five patients with Tourette's syndrome were administered a mean dose of 512 mg/kg per day of oral lecithin. None of the patients exhibited sustained clinical improvement in symptom severity. No significant changes in serum prolactin or growth hormone were observed during lecithin administration.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).